Successful Management of Pemphigus vulgaris in dogs with Prednisolone
95 / 57
Abstract
Two dogs were presented to Small Animal Clinics Out-Patient Dermatology Unit (SAC-OPDU) at Madras Veterinary College Teaching Hospital (MVCTH) with oral ulcers and erosions on gums and palate. The oral lesions and erosions were positive for direct Nikolskiy’s sign and the samples from the lesions were also negative for bacterial and fungal infections.Direct Impression smears from the ulcers and erosions of the two animals were taken and subjected to cytology which showed the presence of acantholytic cells surrounded by neutrophils. Based on the cytology evaluation and distribution of lesion it was confirmed as Pemphigus vulgaris (PV). Both the animals were treated with prednisolone at 0.5 mg/kg body weight for a month along with supplements such as omega fatty acids and vitamins. Improvement was observed in two cases but one dog showed recurrence of lesions after 2 weeks of discontinuation of prednisolone. Complete blood count and serum biochemistry values of the dogs remained within normal limits throughout therapy. since recurrence is common in Pemphigus in dogs, it is concluded that prednisolone is effective in managing Pemphigus vulgaris in dogs and prednisolone can be tapered to the lowest effective dose for prolonged period to avoid recurrence.
Downloads
References
Almela, R.M. and Chan, T. 2021. Review of Pemphigus Foliaceus in Dogs and Cats. Today’s Veterinary Practice. October 6. todaysveterinarypractice.com/dermatology/review-of-pemphigus-foliaceus-in-dogs-and-cats/
Foster, A. and Foil, C. 2003. Manual of Small Animal Dermatology. 2 nd ed., British Small Animal Veterinary Association, Cheltenham. 312.
Gregoriou, S., Efthymiou, O., Stefanaki, C. and Rigopoulos, D. 2015. Management of pemphigus vulgaris: challenges and solutions. Clin. Cosmet. Investig. Dermatol.,8:521-527.
Jordan, T.J.M., Affolter, V.K., Outerbridge, C.A., Goodale, E.C. and White, S.D. 2019. Clinicopathological findings and clinical outcomes in 49 cases of feline pemphigus foliaceus examined in northern California, USA (1987–2017). Vet Dermatol., 30(3):209.
Molla, F. W., Molla, T. W., Yitibarek, D., Demisie, Y., and Legese, K. 2016. Common immune mediated skin disease of dog. Adv. Biotech.and Micro., 1(4):75-82.
Mueller, R.S., Krebs, I., Power, H.T. and Fieseler, K.V. 2006. Pemphigus foliaceus in 91 dogs. J. Am. Anim. Hosp. Assoc., 42:189–196.
Muller, W.H., Griffin, C.E. and Campbell, K.L. 2003. Muller and Kirk’s Small Animal Dermatology. 7th ed. St. Louis, Missouri: Elsevier.
Olivry, T., Joubeh, S., Dunston, S. M., Nishiyama, T and Ghohestani, R. F. 2003. Desmoglein‐3 is a target autoantigen in spontaneous canine pemphigus vulgaris. Experimental Dermatol., 12(2): 198-203.
Olivry, T. 2004. Spontaneous model of pemphigus vulgaris. Animal models of human inflammatory skin diseases, 263-273.
Olivry, T and Linder, K. E. 2009. Dermatoses affecting desmosomes in animals: a mechanistic review of acantholytic blistering skin diseases. Vet. Derm., 20(5‐6): 313-326.
Rory, B. 2008. Autoimmune Skin Diseases-The Old and the New World Small animal Veterinary Association World Congress, Dublin, Ireland https://www.vin.com/doc/?id=3866607
Spriggs, T.S., Gedon, N.K.Y., Linder, K.E. and Bizikova, P. 2024. Comparison of selected cytomorphological features of canine pemphigus foliaceus and superficial pyoderma. Vet. Derm.,35:524-535.
Vaughan, D.F., Hodgin, C.E, Hosgood, G.L. and Bernstein, J.A. 2010. Clinical and histopathological features of pemphigus foliaceus with and without eosinophilic infiltrates: a retrospective evaluation of 40 dogs. Vet Dermatol., 21(2):166-174.